These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4363071)

  • 41. [An unusual virilizing association: arrhenoblastoma and Stein-Leventhal syndrome].
    Lodi A; Grigioni F; Ravaglia G; Ravaioli R; Bazzocchi F; Gritti F; Monti D
    G Clin Med; 1974 Nov; 55(11):759-71. PubMed ID: 4377769
    [No Abstract]   [Full Text] [Related]  

  • 42. [Blood levels of beta-endorphin and beta-lipotropin in patients with Cushing's syndrome].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Ter Arkh; 1981; 53(12):107-10. PubMed ID: 6278666
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cushing's syndrome with marked osteoporosis].
    Ogawa M; Saito T; Tsutsui K; Kaneko K; Ishikawa S
    Horumon To Rinsho; 1983 Sep; 31(9):853-6. PubMed ID: 6315277
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subclinical Cushing's syndrome due to adrenal myelolipoma.
    Boronat M; Moreno A; Ramón y Cajal S; Pineda E; Lucas T; Estrada J
    Arch Pathol Lab Med; 1997 Jul; 121(7):735-7. PubMed ID: 9240911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 'Not Cushing's syndrome'.
    Rincón J; Greenblatt RB; Schwartz RP
    Am Fam Physician; 1979 May; 19(5):77-86. PubMed ID: 220864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CUSHING'S SYNDROME.
    STIRLING WB
    Br J Urol; 1963 Dec; 35():342-52. PubMed ID: 14077791
    [No Abstract]   [Full Text] [Related]  

  • 49. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hyperprolactinemia in Cushing's disease].
    Bruno OD; Pinkas M; Rossi MA
    Medicina (B Aires); 1985; 45(1):5-10. PubMed ID: 2851694
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cushing's disease presenting as pubertal arrest.
    Zadik Z; Cooper M; Chen M; Stern N
    J Pediatr Endocrinol; 1993; 6(2):201-4. PubMed ID: 8348226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Blood amino acids pattern in Cushing's syndrome].
    Morosini PP; Campanella N; Butini L; Maniscalco L; Sabbatini A; Marcolini P
    G Clin Med; 1983 Dec; 64(12):555-9. PubMed ID: 6231207
    [No Abstract]   [Full Text] [Related]  

  • 54. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 55. [Polycystic ovaries: specific disease picture or nonspecific symptom?].
    Moltz L; Sörensen R; Römmler A; Schwartz U; Hammerstein J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):107-14. PubMed ID: 3920114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing's syndrome: what have we learned in 14 years?
    Nieman L
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2876-8. PubMed ID: 17682087
    [No Abstract]   [Full Text] [Related]  

  • 57. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bromocriptine in Nelson's syndrome and Cushing's disease.
    Lamberts SW; Birkenhäger JC
    Lancet; 1976 Oct; 2(7989):811. PubMed ID: 61490
    [No Abstract]   [Full Text] [Related]  

  • 59. An ovarian lipid cell tumour causing virilization and Cushing's syndrome.
    Elhadd TA; Connolly V; Cruickshank D; Kelly WF
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):723-5. PubMed ID: 8759186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma prolactin and dehydroepiandrosterone sulfate levels in polycystic ovarian disease.
    Lee JY; Yoon BK; Moon SY; Kim JG; Chang YS
    Asia Oceania J Obstet Gynaecol; 1987 Jun; 13(2):215-20. PubMed ID: 2957985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.